# Clinical Evaluation of DCB-WH1 in Healing of Chronic Diabetic Foot Ulcers

> **NCT00709514** · PHASE2 · COMPLETED · sponsor: **Oneness Biotech Co., Ltd.** · enrollment: 41 (actual)

## Conditions studied

- Chronic Diabetic Foot Ulcer

## Interventions

- **DRUG:** DCB-WH1 ointment
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00709514
- **Lead sponsor:** Oneness Biotech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2011-04
- **Final completion:** 2012-03
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2013-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00709514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00709514, "Clinical Evaluation of DCB-WH1 in Healing of Chronic Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00709514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*